. . "FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer"@en . . . . . "FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer" . "Ul\u010Dov\u00E1, Hana" . . . . "11130" . "Immunotherapy has emerged as another treatment modality in cancer. The goal of immunotherapy in advanced cancer patients does not have to be the complete eradication of tumor cells but rather the restoration of a dynamic balance between tumor cells and the immune response. Appropriate combination of tumor mass reduction (by surgery and/or chemotherapy) and neutralization of tumor-induced immunosuppression might set the right conditions for the induction of anti-tumor immune response by active immunotherapy. We review experimental basis and key concepts of combined chemo-immunotherapy and document its principles in the case report of patient with hormone refractory metastatic prostate cancer with sinister prognosis. Because of the high frequency of circulating Tregs in our patients, we first administered metronomic cyclophosphamide. After obtaining IRB approval, we started regular vaccinations with dendritic cells (DCs) loaded with killed prostate cancer cells. In accordance with the principles of com"@en . "10"^^ . . . . "RIV/00216208:11130/09:5356" . . "FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer"@en . "Budinsk\u00FD, V\u00EDt" . "000264835000001" . . "12"^^ . . . . "13"^^ . . . . "Prausov\u00E1, Jana" . . "\u0160p\u00ED\u0161ek, Radek" . . . "Min\u00E1rik, Ivo" . . "\u0160ediv\u00E1, Anna" . . . "FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer" . "Clinical Immunology" . "La\u0161\u0165ovi\u010Dka, Jan" . "Ro\u017Ekov\u00E1, Daniela" . . "[93483A14B45F]" . "RIV/00216208:11130/09:5356!RIV10-GA0-11130___" . . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . . "P(GA310/08/0838), Z(MSM0021620812)" . . . "1" . . "Podrazil, Michal" . "Bart\u016F\u0148kov\u00E1, Ji\u0159ina" . . . . "131" . "Linke, Zden\u011Bk" . "Ti\u0161erov\u00E1, Hana" . . "Dendritic cells; Cancer immunotherapy; Prostate cancer; Chemo-immunotherapy; PSA; regulatory t-cells; dying tumor-cells; dendritic cells; immune-responses; ovarian-cancer; chemotherapy; exposure; immunotherapy; calreticulin; vaccine"@en . "1521-6616" . . "315315" . . . "Immunotherapy has emerged as another treatment modality in cancer. The goal of immunotherapy in advanced cancer patients does not have to be the complete eradication of tumor cells but rather the restoration of a dynamic balance between tumor cells and the immune response. Appropriate combination of tumor mass reduction (by surgery and/or chemotherapy) and neutralization of tumor-induced immunosuppression might set the right conditions for the induction of anti-tumor immune response by active immunotherapy. We review experimental basis and key concepts of combined chemo-immunotherapy and document its principles in the case report of patient with hormone refractory metastatic prostate cancer with sinister prognosis. Because of the high frequency of circulating Tregs in our patients, we first administered metronomic cyclophosphamide. After obtaining IRB approval, we started regular vaccinations with dendritic cells (DCs) loaded with killed prostate cancer cells. In accordance with the principles of com" . "Fu\u010D\u00EDkov\u00E1, Jitka" . .